| Dr Cyrus Samai, MD | |
|
1400 Tullie Rd Ne Ste 630, Atlanta, GA 30329-2309 | |
| (404) 256-2593 | |
| Not Available |
| Full Name | Dr Cyrus Samai |
|---|---|
| Gender | Male |
| Speciality | Pediatrics - Pediatric Cardiology |
| Location | 1400 Tullie Rd Ne Ste 630, Atlanta, Georgia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104861699 | NPI | - | NPPES |
| 555872551A | Medicaid | GA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2080P0202X | Pediatrics - Pediatric Cardiology | 054662 (Georgia) | Primary |
| Entity Name | Union County Hospital Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487684122 PECOS PAC ID: 3779490503 Enrollment ID: O20040102000231 |
News Archive
Consuming large amounts of caffeine while taking acetaminophen, one of the most widely used painkillers in the United States, could potentially cause liver damage, according to a preliminary laboratory study reported in the Oct. 15 print issue of ACS' Chemical Research in Toxicology, a monthly journal.
Researchers at the Wyss Institute at Harvard University, in collaboration with healthcare, research, and industrial partners, have designed a new, fully injection-molded nasopharyngeal swab that can be manufactured quickly and inexpensively at high volume to help address the nationwide and international shortage of swabs for COVID-19 testing and research.
Analysis published in Drug Discovery Today reveals the gap between animal models of Parkinson's disease and our understanding of the neurodegenerative processes underlying the disease, and calls for the implementation of modern, human biology-based technologies to better understand pathological processes and improve treatment outcome.
New research may allow new, more effective and safer pain medications to reach patients who suffer from chronic pain sooner. According to a recent study published in Anesthesiology, the official medical journal of the American Society of Anesthesiologists, using functional magnetic resonance imaging (FMRI), to measure the brain's neural response to pain, may be a viable tool for evaluating the effectiveness of new pain medications during the early stages of human drug development - providing the needed objective evidence to prevent the premature discarding of potentially beneficial therapies.
› Verified 9 days ago
| Entity Name | Children's Healthcare Of Atlanta Cardiology Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235148727 PECOS PAC ID: 6901888395 Enrollment ID: O20040601000805 |
News Archive
Consuming large amounts of caffeine while taking acetaminophen, one of the most widely used painkillers in the United States, could potentially cause liver damage, according to a preliminary laboratory study reported in the Oct. 15 print issue of ACS' Chemical Research in Toxicology, a monthly journal.
Researchers at the Wyss Institute at Harvard University, in collaboration with healthcare, research, and industrial partners, have designed a new, fully injection-molded nasopharyngeal swab that can be manufactured quickly and inexpensively at high volume to help address the nationwide and international shortage of swabs for COVID-19 testing and research.
Analysis published in Drug Discovery Today reveals the gap between animal models of Parkinson's disease and our understanding of the neurodegenerative processes underlying the disease, and calls for the implementation of modern, human biology-based technologies to better understand pathological processes and improve treatment outcome.
New research may allow new, more effective and safer pain medications to reach patients who suffer from chronic pain sooner. According to a recent study published in Anesthesiology, the official medical journal of the American Society of Anesthesiologists, using functional magnetic resonance imaging (FMRI), to measure the brain's neural response to pain, may be a viable tool for evaluating the effectiveness of new pain medications during the early stages of human drug development - providing the needed objective evidence to prevent the premature discarding of potentially beneficial therapies.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Cyrus Samai, MD 2835 Brandywine Rd, #300, Atlanta, GA 30341-5510 Ph: (404) 256-2593 | Dr Cyrus Samai, MD 1400 Tullie Rd Ne Ste 630, Atlanta, GA 30329-2309 Ph: (404) 256-2593 |
News Archive
Consuming large amounts of caffeine while taking acetaminophen, one of the most widely used painkillers in the United States, could potentially cause liver damage, according to a preliminary laboratory study reported in the Oct. 15 print issue of ACS' Chemical Research in Toxicology, a monthly journal.
Researchers at the Wyss Institute at Harvard University, in collaboration with healthcare, research, and industrial partners, have designed a new, fully injection-molded nasopharyngeal swab that can be manufactured quickly and inexpensively at high volume to help address the nationwide and international shortage of swabs for COVID-19 testing and research.
Analysis published in Drug Discovery Today reveals the gap between animal models of Parkinson's disease and our understanding of the neurodegenerative processes underlying the disease, and calls for the implementation of modern, human biology-based technologies to better understand pathological processes and improve treatment outcome.
New research may allow new, more effective and safer pain medications to reach patients who suffer from chronic pain sooner. According to a recent study published in Anesthesiology, the official medical journal of the American Society of Anesthesiologists, using functional magnetic resonance imaging (FMRI), to measure the brain's neural response to pain, may be a viable tool for evaluating the effectiveness of new pain medications during the early stages of human drug development - providing the needed objective evidence to prevent the premature discarding of potentially beneficial therapies.
› Verified 9 days ago
Dr. Seth Benjamin Marcus, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 993-d Johnson Ferry Rd Ne Suite 440, Atlanta, GA 30342 Phone: 404-257-0799 | |
Carrie Ng, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1405 Clifton Rd Ne, Atlanta, GA 30322 Phone: 404-785-7141 Fax: 404-785-7989 | |
Dr. Bharath Srivatsa, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 5901 Peachtree Dunwoody Rd Ne, Suite B 420, Atlanta, GA 30328 Phone: 404-252-9751 Fax: 678-990-5763 | |
Michael Mallory, MD, MPH Pediatrics Medicare: Medicare Enrolled Practice Location: 1001 Johnson Ferry Rd Ne, Atlanta, GA 30342 Phone: 404-250-2972 | |
Briana Cary Patterson, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 2015 Uppergate Dr, Atlanta, GA 30322 Phone: 404-727-6721 | |
Evan Orenstein, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1405 Clifton Rd Ne, Atlanta, GA 30322 Phone: 404-785-6104 Fax: 404-785-1462 | |
Andrew John Galway Mcreynolds, Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 49 Jesse Hill Jr Dr Se, Pediatrics Residency Training Program, Atlanta, GA 30303 Phone: 404-778-1440 |